A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients
Top Cited Papers
- 11 October 2001
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 345 (15) , 1091-1097
- https://doi.org/10.1056/nejmoa010957
Abstract
Adjuvant chemotherapy is standard treatment for patients with resected colon cancer who are at high risk for recurrence, but the efficacy and toxicity of such treatment in patients more than 70 years of age are controversial.Keywords
This publication has 44 references indexed in Scilit:
- Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment TrialsNew England Journal of Medicine, 1999
- Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle numberEuropean Journal Of Cancer, 1998
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994
- Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acidEuropean Journal Of Cancer, 1992
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Cancer treatment protocols. Who gets chosen?Archives of internal medicine (1960), 1988
- Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancerBritish Journal of Surgery, 1987
- Clinical trials and drug toxicity in the elderly. The experience of the eastern cooperative oncology groupCancer, 1983
- Dose-Response Effect of Adjuvant Chemotherapy in Breast CancerNew England Journal of Medicine, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958